Skip to main content
. 2019 Nov 15;35(1):12–24. doi: 10.3904/kjim.2019.271

Table 2.

Potential role of MCs in RA pathogenesis and future research agenda

Field Agenda Reference
Angiogenesis of RA synovium Roles of MC origin mediators (such as tryptase, chymase, histamine) on neo-angiogensis of RA synovium [47,48]
Chemoattractive role in RA synovium Ability to recruit various immune cells, neutrophil, NK cell, T cell, monocytes via secreting chemokines (TNF-α, CCL2, CCL5, IL-8, LTB4) [86]
APC function Activation of other immune cells, such as T cells, via antigen presenting function of MC [64,65,66,87]
Osteoclastogenesis Osteoclastogenesis via histamine secreted by MCs [39,40]
Pharmacologic intervention c-kit tyrosine kinase inhibitor (imatinib) treatment induced apoptosis of MCs and reduced TNF-α production in RA synovium [60]
Anti-allergic medication, tranilast, suppressed TNF-α production in MC of RA mice model [61]
MC suppression by salbutamol and cromolyn reduced joint destruction and angiogenesis in RA mice model [79]

MC, mast cell; RA, rheumatoid arthritis; NK, natural killer; TNF-α, tumor necrosis factor-α; CCL, CC chemokine ligand; IL, interleukin; LTB4, leukotriene B4; APC, antigen presenting cell.